Sang Yull Kang

Sang Yull Kang

Auto-generated profile, based on publicly available information

Sang Yull Kang

Department of Surgery, Research Institute of Clinical Medicine, Jeonbuk National University Hospital, Biomedical Research Institute, Jeonbuk National University, Jeonju, 54907, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SKSang Yull Kang
Sang Yull Kang
YKYoo Seok Kim
Yoo Seok Kim
ZKZisun Kim
Zisun Kim
HKHyun Yul Kim
Hyun Yul Kim
HKHee Jeong Kim
Hee Jeong Kim
TSThe Korean Breast Cancer Society
The Korean Breast Cancer Society
Kang SY, et al. J Breast Cancer. 2019 Nov;23:e24. https://doi.org/10.4048/jbc.2020.23.e24

1 January 2021 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SKSang Yull Kang
Sang Yull Kang
SLSae Byul Lee
Sae Byul Lee
YKYoo Seok Kim
Yoo Seok Kim
ZKZisun Kim
Zisun Kim
HKHyun Yul Kim
Hyun Yul Kim
KSKorean Breast Cancer Society
Korean Breast Cancer Society
Kang SY, et al. J Breast Cancer. 2021 Apr;24(2):123-137. https://doi.org/10.4048/jbc.2021.24.e22

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
HAHa Rim Ahn
Ha Rim Ahn
SKSang Yull Kang
Sang Yull Kang
HYHyun Jo Youn
Hyun Jo Youn
SJSung Hoo Jung
Sung Hoo Jung
Ahn HR, et al. J Breast Cancer. 2019 Nov;23:e44. https://doi.org/10.4048/jbc.2020.23.e44

1 August 2012 in Materials Science in Semiconductor Processing
Verified
Journal Article
Closed access
KSK-H. Shim
K-H. Shim
YKY-H. Kil
Y-H. Kil
HYH.D. Yang
H.D. Yang
BPB.K. Park
B.K. Park
JYJ-H. Yang
J-H. Yang
TKTaek Sung Kim
Taek Sung Kim

1 June 2020 in Korean Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
HAHa Rim Ahn
Ha Rim Ahn
SKSang Yull Kang
Sang Yull Kang
HYHyun Jo Youn
Hyun Jo Youn
SJSung Hoo Jung
Sung Hoo Jung
The extent of surgery necessary in patients with unilateral papillary thyroid carcinoma (PTC) on preoperative radiologic imaging is still in doubt. In this study, we aimed to define risk factors that could be indicators for malignant nodules in the contralateral thyroid lobe. We included 438 patients who underwent total thyroidectomy between January 2011 and December 2014 at our institution. In this study, patients were divided into two groups according to the presence of contralateral occult carcinoma identified by postoperative pathological examination. We analyzed the clinicopathologic factors including characteristics of coexistent nodules in the contralateral lobe based on preoperative radiological imaging. A total of 96 patients (21.9%) had PTC in the contralateral lobe. There were no significant differences between patients with or without contralateral occult carcinoma with respect to gender, age, primary tumor size, central lymph node metastasis, extrathyroidal extension and stage. The presence of Hashimoto’s thyroiditis was an independent predictive factor for contralateral occult carcinoma (P=0.01). A risk factor for contralateral occult carcinoma in unilateral PTC patients is Hashimoto’s thyroiditis. Therefore, more caution is needed when determining optimal surgical methods for PTC patients with Hashimoto’s thyroiditis.

11 July 2024 in Current Medical Imaging
Verified
Journal Article
Open access
PDF file
SKSang Yull Kang
Sang Yull Kang
ECEun Jung Choi
Eun Jung Choi
Kyu JangKyu Jang
Kyu Jang
Background: Dermatofibrosarcoma Protuberans (DFSP) is a rare soft tissue sarcoma, accounting for approximately 1% of all tumors; however, DFSP of the breast is extremely rare. Moreover, DFSP generally has a low malignant potential and is characterized by a high rate of local recurrence along with a small but definite risk of metastasis. The risk of metastasis is higher in fibrosarcomatous transformation in DFSP than in ordinary DFSP. Case Report: We have, herein, reported a case of a 61-year-old male patient with fibrosarcomatous transformation in DFSP. Preoperative Dynamic Contrastenhanced Magnetic Resonance Imaging (DCE-MRI) of the breast revealed an oval-shaped mass with heterogeneous internal enhancement, a large vessel embedded within, and a washout curve pattern on kinetic curve analysis. The mass exhibited a hyperintense signal on Diffusion-weighted Imaging (DWI), with a low apparent diffusion coefficient value. Histologically, the bland spindle tumor cells were arranged in a storiform pattern. Areas with the highest histological grade demonstrated increased cellularity, cytological atypia, and mitotic activity. Immunohistochemically, Ki-67 and p53 were highly expressed. Conclusion: Recognizing the risk and accurately diagnosing fibrosarcomatous transformation in male breast DFSP are critical for improving prognosis and establishing appropriate treatment and follow-up plans. This emphasizes the significance of combining immunohistopathological features with DCE-MRI and DWI to assist clinicians in the early and accurate diagnosis of sarcomas arising from male breast DFSP.